OBJECTIVE: To determine if pulsed cavitational ultrasound therapy (histotripsy) can accurately and safely generate ventricular septal defects (VSDs) through the intact chest of a neonatal animal, with the eventual goal of developing a noninvasive technique of creating intra-cardiac communications in patients with congenital heart disease. BACKGROUND: Histotripsy is an innovative ultrasonic technique that generates demarcated, mechanical tissue fractionation utilizing high intensity ultrasound pulses. Previous work has shown that histotripsy can create atrial septal defects in a beating heart in an open-chest canine model. METHODS: Nine neonatal pigs were treated with transcutaneous histotripsy targeting the ventricular septum. Ultrasound pulses of 5-μsec duration at a peak negative pressure of 13 MPa and a pulse repetition frequency of 1 kHz were generated by a 1 MHz focused transducer. The procedure was guided by real-time ultrasound imaging. RESULTS: VSDs were created in all pigs with diameters ranging from 2 to 6.5 mm. Six pigs were euthanized within 2 hrs of treatment, while three were recovered and maintained for 2-3 days to evaluate lesion maturation and clinical side effects. There were only transient clinical effects and pathology revealed mild collateral damage around the VSD with no significant damage to other cardiac or extra-cardiac structures. CONCLUSIONS: Histotripsy can accurately and safely generate VSDs through the intact chest in a neonatal animal model. These results suggest that with further advances, histotripsy can be a useful, noninvasive technique to create intracardiac communications, which currently require invasive catheter-based or surgical procedures, to clinically stabilize newborn infants with complex congenital heart disease.
OBJECTIVE: To determine if pulsed cavitational ultrasound therapy (histotripsy) can accurately and safely generate ventricular septal defects (VSDs) through the intact chest of a neonatal animal, with the eventual goal of developing a noninvasive technique of creating intra-cardiac communications in patients with congenital heart disease. BACKGROUND: Histotripsy is an innovative ultrasonic technique that generates demarcated, mechanical tissue fractionation utilizing high intensity ultrasound pulses. Previous work has shown that histotripsy can create atrial septal defects in a beating heart in an open-chest canine model. METHODS: Nine neonatal pigs were treated with transcutaneous histotripsy targeting the ventricular septum. Ultrasound pulses of 5-μsec duration at a peak negative pressure of 13 MPa and a pulse repetition frequency of 1 kHz were generated by a 1 MHz focused transducer. The procedure was guided by real-time ultrasound imaging. RESULTS: VSDs were created in all pigs with diameters ranging from 2 to 6.5 mm. Six pigs were euthanized within 2 hrs of treatment, while three were recovered and maintained for 2-3 days to evaluate lesion maturation and clinical side effects. There were only transient clinical effects and pathology revealed mild collateral damage around the VSD with no significant damage to other cardiac or extra-cardiac structures. CONCLUSIONS: Histotripsy can accurately and safely generate VSDs through the intact chest in a neonatal animal model. These results suggest that with further advances, histotripsy can be a useful, noninvasive technique to create intracardiac communications, which currently require invasive catheter-based or surgical procedures, to clinically stabilize newborn infants with complex congenital heart disease.
Authors: Jean Ninet; Xavier Roques; Rainald Seitelberger; Claude Deville; Jose Luis Pomar; Jacques Robin; Olivier Jegaden; Francis Wellens; Ernst Wolner; Catherine Vedrinne; Roman Gottardi; Javier Orrit; Marc-Alain Billes; Drew A Hoffmann; James L Cox; Gerard L Champsaur Journal: J Thorac Cardiovasc Surg Date: 2005-09 Impact factor: 5.209
Authors: Axel Häcker; Kai Uwe Köhrmann; Walter Back; Oliver Kraut; Ernst Marlinghaus; Peter Alken; Maurice Stephan Michel Journal: BJU Int Date: 2005-07 Impact factor: 5.588
Authors: P M Seib; S C Faulkner; C C Erickson; S H Van Devanter; J E Harrell; J W Fasules; E A Frazier; W R Morrow Journal: Catheter Cardiovasc Interv Date: 1999-02 Impact factor: 2.692
Authors: Eli Vlaisavljevich; Adam Maxwell; Lauren Mancia; Eric Johnsen; Charles Cain; Zhen Xu Journal: Ultrasound Med Biol Date: 2016-07-09 Impact factor: 2.998
Authors: Eli Vlaisavljevich; Yohan Kim; Gabe Owens; William Roberts; Charles Cain; Zhen Xu Journal: Phys Med Biol Date: 2013-12-19 Impact factor: 3.609
Authors: Simone Park; Adam D Maxwell; Gabe E Owens; Hitinder S Gurm; Charles A Cain; Zhen Xu Journal: Ultrasound Med Biol Date: 2013-02-13 Impact factor: 2.998
Authors: Jonathan J Macoskey; Xi Zhang; Timothy L Hall; Jiaqi Shi; Shahaboddin Alahyari Beig; Eric Johnsen; Fred T Lee; Charles A Cain; Zhen Xu Journal: Ultrasound Med Biol Date: 2018-01-09 Impact factor: 2.998
Authors: Babak Nazer; Edward P Gerstenfeld; Akiko Hata; Lawrence A Crum; Thomas J Matula Journal: J Interv Card Electrophysiol Date: 2013-12-03 Impact factor: 1.900